Lactated Ringer’s Injections Recalled Due to the Presence of Particulate Matter

Key Takeaways:

• The US Food and Drug Administration (FDA) has issued a voluntary Class I recall for Lactated Ringer’s injections USP, 1000 mL. The affected batches have been identified as Lots J4P756 and J4S843 (expiration date May 31, 2027), affecting 95 412 containers.
• The recall was initiated by B Braun Medical, Inc due to the presence of particulate matter, a quality issue that may cause serious adverse health consequences or death.
• Lactated Ringer’s injections are used either as a source of hydration for patients with low blood pressure or as an alkalizing agent.

The FDA has issued a Class I recall for Lactated Ringer’s injections USP, 1000 mL. This medication is being recalled by B Braun Medical, Inc, based in Allentown, Pennsylvania. The recall was initiated on April 28, 2026, and received a Class I classification on May 18, 2026.

The recall was initiated due to the presence of particulate matter, which means the product contains foreign containments. This contamination particularly affects Lots J4P756 and J4S843, which expire on May 31, 2027. A Class I classification means the use of this product may cause serious adverse health consequences or death. B Braun Medical sent out a public notice via press release for this recall.

Lactated Ringer’s injections are used to replenish water and electrolyte loss in patients with low blood pressure. They can also be used as an alkalizing agent to raise pH levels. Pharmacists should identify and quarantine Lots J4P756 and J4S843, remove them from inventory, and coordinate with prescribers to provide an alternative supply.

Reference

FDA. Enforcement Report. May 13, 2026. Accessed May 20, 2026. https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=219843